HOMOEOPATHIC MEDICINE IN THE TREATMENT OF PITYRIASIS ALBA IN PAEDIATRIC AGE GROUP

A CLINICAL STUDY ON THE EFFECTIVENESS OF HOMOEOPATHIC MEDICINE IN THE TREATMENT OF PITYRIASIS ALBA IN PAEDIATRIC AGE GROUP - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063153

Enrollment

Registered

2024-02-26

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L819- Disorder of pigmentation, unspecified

Interventions

Intervention1: Homoeopathic constitutional medicine: Dosage and repetition based on patients susceptibility.Dose is given as minimum to moderate doses starting with 30th potency and repetition based o

Eligibility

Inclusion criteria

Inclusion criteria: patients within the paediatric age group 3-18,both genders,child showing the characteristic clinical picture of pityriasis alba will be taken

Exclusion criteria

Exclusion criteria: Child having skin diseases due to Dermatophytosis and other hypo pigmented conditions,child under topical steroids treatment,age less than 3 years and above 18 yrs.

Design outcomes

Primary

Measure	Time frame
primary outcome is evaluated by looking the target area changes in the case of pityiriasis alba of children using pre and post photographic evidence.Timepoint: case will be reviewed every 2 weeks and first expected outcome is evaluated within 3 months	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactKrishnapriya R

sarada krishna homoeopathic medical college

drsisirpr@rediffmail.com9443474941

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026